insights_auto
Bakit bumaba ang EDIT 4.09%?
Tingnan ang Higit pang Detalyechevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.64
arrow_downward
-4.09%(-0.070) 1D
$1.66
arrow_upward
+1.22% (+0.020)bedtimePagkalipas ng oras ng trabaho
Sarado: Nob 20, 4:00:00 PM GMT-5 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EDIT...
Buksan
$1.69
Mataas
$1.78
Mababa
$1.63
Mkt. cap
253.12M
Avg. na dami
2.24M
Dami
2.68M
Mataas nang 52-wk
$3.94
Mababa nang 52-wk
$1.63
EPS
-$0.62
Beta
2.09
Mga natitirang share
154.34M
Bilang ng mga empleyado
87
Buksan
$1.69
Mataas
$1.78
Mababa
$1.63
Mkt. cap
253.12M
Avg. na dami
2.24M
Dami
2.68M
Mataas nang 52-wk
$3.94
Mababa nang 52-wk
$1.63
EPS
-$0.62
Beta
2.09
Mga natitirang share
154.34M
Bilang ng mga empleyado
87
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
FOREX.com
·
3 oras ang nakalipas
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingView
·
4 oras ang nakalipas
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
TradingKey
·
8 oras ang nakalipas
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
2 oras ang nakalipas
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Tungkol sa Editas Medicine Inc
CEO-
Mga Empleyado87
ItinatagNob 2013
Headquarters-
SektorHealth Care
Industriya-
Websiteeditasmedicine.com